Acne rosacea (acne erythematosa; ocular rosacea)

General: Etiology unknown; usually occurs in wo 222j99c men 30 to 50 years of age; pathogenetic mechanism remains unclear.

Ocular: Conjunctivitis; corneal neovascularization (wedge-shaped); keratitis; meibomianitis; blepharitis; recurrent chalazion; conjunctival hyperemia; superficial punctate keratopathy; corneal vascularization, thinning, perforation, and scarring; episcleritis; scleritis; iritis; nodular conjunctivitis.

Clinical: Symmetrical erythema; papules; pustules; telangiectasia; sebaceous gland hypertrophy of the forehead, malar eminences, and nose.

Browning DJ, et al. Ocular rosacea in blacks. Am J Ophthalmol 1986; 101:441-444.

Collins JF. Handbook of Clinical Ophthalmology. New York: Masson, 1982:267-268.

Fraunfelder FT, Roy FH. Current Ocular Therapy, 5th ed. Philadelphia: WB Saunders, 2000.

Hozng-Xuan T, et al. Ocular rosacea. Ophthalmology 1990; 97:1468.

Marmion VJ. Tetracycline in the treatment of ocular rosacea. Proc Roy Soc Med 1969; 62: 11-l2.

Mondino BJ. Clinical immunologic diseases. Dermatologic disease. In: Smolin G, Thoft RA, eds. The Cornea, 3^rd ed. Boston: Little, Brown and Company, 1994:428-431.

Pavan-Langston D. Rosacea (acne rosacea). In: Pavan-Langston D, ed. Manual of ocular diagnosis and therapy. Boston: Little, Brown and Company, 1995:104-l05.

Roper-Hall MJ. The ocular aspects of rosacea. Trans Ophthalmol Soc U K